Shenglan Tan
Impact in
-
- Medicinal plant effects and applications
- Geriatrics and Gerontology top 10%
Papers in
-
- Natural product bioactivities and synthesis 4
- Biological Activity of Diterpenoids and Biflavonoids 3
- Bone Metabolism and Diseases 2
-
- Medicinal plant effects and applications 5
- Co-authors
- Bikui Zhang (5 shared papers)Ping Xu (8 shared papers)Yang Deng (4 shared papers)Pei Jiang (3 shared papers)Yangzhao Zhou (3 shared papers)Jie Du (1 shared paper)Shanshan Wei (1 shared paper)Xiaohui Li (1 shared paper)
- Journals
- Journal of Cancer (2 papers)BMC Medical Education (2 papers)BMC Health Services Research (2 papers)Frontiers in Pharmacology (2 papers)Organic & Biomolecular Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Shenglan Tan
27 papers receiving 460 citations
Peers
Comparison fields: 5 of 94
- Complementary and alternative medicine 67
- Geriatrics and Gerontology 24
- Pharmacology 53
- Molecular Medicine 26
- Cancer Research 55
Countries citing papers authored by Shenglan Tan
This map shows the geographic impact of Shenglan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglan Tan more than expected).
Fields of papers citing papers by Shenglan Tan
This network shows the impact of papers produced by Shenglan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglan Tan. The network helps show where Shenglan Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenglan Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 54 | |
| 2 | 2017 | 51 | |
| 3 | 2020 | 47 | |
| 4 | 2018 | 41 | |
| 5 | 2011 | 36 | |
| 6 | 2012 | 28 | |
| 7 | 2020 | 24 | |
| 8 | 2018 | 19 | |
| 9 | 2013 | 18 | |
| 10 | 2020 | 16 | |
| 11 | 2016 | 15 | |
| 12 | 2013 | 12 | |
| 13 | 2012 | 12 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 11 | |
| 16 | 2010 | 10 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 1986 | 8 |
About Shenglan Tan
Shenglan Tan is a scholar working on Molecular Biology, Complementary and alternative medicine, Infectious Diseases, Cardiology and Cardiovascular Medicine and Cancer Research, having authored 31 papers that have together received 466 indexed citations. Recurring topics across this work include Medicinal plant effects and applications (5 papers), Natural product bioactivities and synthesis (4 papers), Biological Activity of Diterpenoids and Biflavonoids (3 papers), Bone Metabolism and Diseases (2 papers), Health Policy Implementation Science (1 paper), Electric Vehicles and Infrastructure (1 paper), Advanced Battery Technologies Research (1 paper) and Venous Thromboembolism Diagnosis and Management (1 paper). The work is most often cited by research in Complementary and alternative medicine (67 citations), Geriatrics and Gerontology (24 citations), Pharmacology (53 citations), Molecular Medicine (26 citations) and Cancer Research (55 citations). Shenglan Tan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Bikui Zhang, Ping Xu, Yang Deng, Pei Jiang, Yangzhao Zhou, Jie Du, Shanshan Wei, Xiaohui Li, Daxiong Xiang and Qiong Lu. Their work appears in journals such as Journal of Cancer, BMC Medical Education, BMC Health Services Research, Frontiers in Pharmacology and Organic & Biomolecular Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.